Literature DB >> 26073937

Editorial: Emerging Targets for Stimulant Use Disorders: Where To Invest In An Era Of Constrained Resources?

Phil Skolnick, David White, Jane B Acri1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26073937     DOI： 10.2174/187152731406150624122404

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN： 1871-5273            Impact factor:   4.388


× No keyword cloud information.
  11 in total

1.  Effectiveness of a Cocaine Hydrolase for Cocaine Toxicity Treatment in Male and Female Rats.

Authors:  Xirong Zheng; Ziyuan Zhou; Ting Zhang; Zhenyu Jin; Xiabin Chen; Jing Deng; Chang-Guo Zhan; Fang Zheng
Journal:  AAPS J       Date:  2017-11-27       Impact factor: 4.009

2.  A quantitative LC-MS/MS method for simultaneous determination of cocaine and its metabolites in whole blood.

Authors:  Xiabin Chen; Xirong Zheng; Kai Ding; Ziyuan Zhou; Chang-Guo Zhan; Fang Zheng
Journal:  J Pharm Biomed Anal       Date:  2016-11-11       Impact factor: 3.935

3.  Long-acting cocaine hydrolase for addiction therapy.

Authors:  Xiabin Chen; Liu Xue; Shurong Hou; Zhenyu Jin; Ting Zhang; Fang Zheng; Chang-Guo Zhan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-28       Impact factor: 11.205

4.  Effects of a cocaine hydrolase engineered from human butyrylcholinesterase on metabolic profile of cocaine in rats.

Authors:  Xiabin Chen; Xirong Zheng; Ziyuan Zhou; Chang-Guo Zhan; Fang Zheng
Journal:  Chem Biol Interact       Date:  2016-05-03       Impact factor: 5.192

5.  Development of Fc-Fused Cocaine Hydrolase for Cocaine Addiction Treatment: Catalytic and Pharmacokinetic Properties.

Authors:  Xiabin Chen; Jing Deng; Wenpeng Cui; Shurong Hou; Jinling Zhang; Xirong Zheng; Xin Ding; Huimei Wei; Ziyuan Zhou; Kyungbo Kim; Chang-Guo Zhan; Fang Zheng
Journal:  AAPS J       Date:  2018-03-19       Impact factor: 4.009

6.  Structure-Based Design and Discovery of a Long-Acting Cocaine Hydrolase Mutant with Improved Binding Affinity to Neonatal Fc Receptor for Treatment of Cocaine Abuse.

Authors:  Fang Zheng; Xiabin Chen; Kyungbo Kim; Ting Zhang; Haifeng Huang; Shuo Zhou; Jinling Zhang; Zhenyu Jin; Chang-Guo Zhan
Journal:  AAPS J       Date:  2020-03-18       Impact factor: 4.009

7.  Metabolic Enzymes of Cocaine Metabolite Benzoylecgonine.

Authors:  Xiabin Chen; Xirong Zheng; Max Zhan; Ziyuan Zhou; Chang-Guo Zhan; Fang Zheng
Journal:  ACS Chem Biol       Date:  2016-06-09       Impact factor: 5.100

8.  Reengineering of Albumin-Fused Cocaine Hydrolase CocH1 (TV-1380) to Prolong Its Biological Half-Life.

Authors:  Yingting Cai; Shuo Zhou; Zhenyu Jin; Huimei Wei; Linyue Shang; Jing Deng; Chang-Guo Zhan; Fang Zheng
Journal:  AAPS J       Date:  2019-11-21       Impact factor: 4.009

9.  Clinical potential of a rationally engineered enzyme for treatment of cocaine dependence: Long-lasting blocking of the psychostimulant, discriminative stimulus, and reinforcing effects of cocaine.

Authors:  Ting Zhang; Huimei Wei; Jing Deng; Fang Zheng; Chang-Guo Zhan
Journal:  Neuropharmacology       Date:  2020-07-22       Impact factor: 5.250

10.  Plant expression of cocaine hydrolase-Fc fusion protein for treatment of cocaine abuse.

Authors:  Guojun Wang; Ting Zhang; Haifeng Huang; Shurong Hou; Xiabin Chen; Fang Zheng; Chang-Guo Zhan
Journal:  BMC Biotechnol       Date:  2016-10-19       Impact factor: 2.563
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.